Published the monthly exercise status for October 2026 of the 35th stock acquisition rights. Number of shares granted: 1,299,900 shares; stock acquisition rights exercised in October: 12,999 units; proportion to total issued: 8.79%; unexercised stock acquisition rights at month-end: 28,396 units (2,839,600 shares).<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"4586","jir_company_name":"MedRx Co., Ltd","jir_importance":"\u2605\u2605\u2605\u2606\u2606","jir_publication_date":"2026-11-02","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/11\/4586-20261102-01.pdf","jir_short_summary":"Published the monthly exercise status for October 2026 of the 35th stock acquisition rights. Number of shares granted: 1,299,900 shares; stock acquisition rights exercised in October: 12,999 units; proportion to total issued: 8.79%; unexercised stock acquisition rights at month-end: 28,396 units (2,839,600 shares).","jir_summary":"### Exercise Status of Stock Acquisition Rights\nThis report summarizes the monthly exercise status for October 2026 of stock acquisition rights issued by third-party allotment. There were exercises on multiple days in October, totaling 12,999 stock acquisition rights exercised, and no transferred treasury shares occurred. The number of shares granted in the relevant month was 1,299,900 shares, indicating a large allotment, and the number of unexercised rights at month-end was 28,396 units. The exercise ratio relative to total issued is 8.79%, and the ratio relative to the exchange rules' exercise restriction is 2.19%.\n\n### Impact and Future Points of Attention\nThe exercise trend is progressing at a steady pace, and it is necessary to note that a substantial number of unexercised rights remain. Depending on future exercise trends, there is potential for dilution effects on treasury shares and changes in the number of outstanding shares. This disclosure is positioned as part of routine monitoring of exercise status.","jir_financial_highlights":"Number of shares granted: 1,299,900 shares (Unknown)\nNumber of stock acquisition rights exercised: 12,999 units (Unknown)\nUnexercised stock acquisition rights (month-end): 28,396 units (From 41,395 units at the end of the previous month \u2192 decrease)","jir_category":"","jir_hashtags":"#MedRxIR, #StockAcquisitionRights, #EquityRelated","jir_key_figures":"Number of shares granted: 1,299,900 shares\nNumber of stock acquisition rights exercised: 12,999 units\nUnexercised stock acquisition rights (month-end): 28,396 units","jir_meta_title":"MedRx Co., Ltd \u2014 Monthly Exercise Status of Stock Acquisition Rights Issued by Third-Party Allotment (October 2026)","jir_meta_description":"MedRx Co., Ltd discloses the monthly exercise status for October 2026 of the 35th stock acquisition rights: 1,299,900 shares granted, 12,999 rights exercised, 28,396 unexercised, exercise ratio 8.79%, exercise restriction ratio 2.19%.","jir_og_title":"MedRx Co., Ltd Announces October Monthly Exercise Status of Stock Acquisition Rights","jir_og_description":"MedRx Co., Ltd discloses October exercise status of the 35th stock acquisition rights: 1,299,900 shares granted, 12,999 exercised, 28,396 unexercised, exercise ratio 8.79%, restricted exercise ratio 2.19%.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":59495,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"stock_option","footnotes":""},"sector":[],"importance":[],"class_list":["post-139338","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n